{{Multiple issues|
{{Rough translation|time=2020-09-16T17:54:16+00:00}}
{{Expand language|1=en|time=2020-09-16T17:54:49+00:00}}
}}
{{Medical}}
{{Drugbox
| Verifiedfields = changed
| verifiedrevid = 461101531
| image = Fluocinolone acetonide.svg
| alt = 
| image2 = Fluocinolone acetonide (Ball-n-Stick).png
| alt2 = 

<!--Clinical data-->
| tradename = Synalar, Iluvien, others
| Drugs.com = {{drugs.com|monograph|fluocinolone-topical}}<br />{{drugs.com|monograph|fluocinolone-acetonide-eent}}
| pregnancy_AU = A
| pregnancy_category = 
| routes_of_administration = Topical, ophthalmic intravitreal injection
| ATC_prefix = C05
| ATC_suffix = AA10
| ATC_supplemental = {{ATC|D07|AC04}} {{ATC|S01|BA15}} {{ATC|S02|BA08}}

| legal_AU = S4
| legal_UK = POM
| legal_US = Rx-only
| legal_status = Rx-only

<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound =  
| metabolism = [[Liver|Liver]], [[CYP3A4|CYP3A4]]-mediated
| elimination_half-life = 1.3 to 1.7 h
| excretion =

<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 67-73-2
| PubChem = 6215
| IUPHAR_ligand = 7077
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = DB00591
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 5980
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 0CD5FD6S2M
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D01825
| ChEBI_Ref = {{ebicite|changed|EBI}}
| ChEBI = 31623
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 989

<!--Chemical data-->
| IUPAC_name = (1''S'',2''S'',4''R'',8''S'',9''S'',11''S'',12''R'',13''S'',19''S'')-12,19-difluoro-11-hydroxy-8-(2-hydroxyacetyl)-6,6,9,13-tetramethyl-5,7-dioxapentacyclo[10.8.0.0<sup>2,9</sup>.0<sup>4,8</sup>.0<sup>13,18</sup>]icosa-14,17-dien-16-one
| C=24 | H=30 | F=2 | O=6
| smiles = O=C\1\C=C5/[C@@](/C=C/1)(C)[C@]2(F)[C@H]([C@H]3[C@](C[C@@H]2O)([C@@]4(OC(O[C@@H]4C3)(C)C)C(=O)CO)C)C[C@@H]5F
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C24H30F2O6/c1-20(2)31-19-9-13-14-8-16(25)15-7-12(28)5-6-21(15,3)23(14,26)17(29)10-22(13,4)24(19,32-20)18(30)11-27/h5-7,13-14,16-17,19,27,29H,8-11H2,1-4H3/t13-,14-,16-,17-,19+,21-,22-,23-,24+/m0/s1
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = FEBLZLNTKCEFIT-VSXGLTOVSA-N
}}

'''醋酸氟轻松'''（英文：Fluocinolone acetonide）是一种皮质类固醇，主要用于治疗皮肤病，减少皮肤炎症和缓解瘙痒。<ref name="druguse">{{cite web |url=http://www.crdu.cn/Database/Index/overviewShow/id/986.do |access-date=2020-09-16 |title=醋酸氟轻松|publisher=临床合理用药}}</ref> 它是合成的氢化可的松衍生物。类固醇核中第9位的氟取代大大增强了它的活性。它于1959年在墨西哥城Syntex实验室研究部门首次合成<ref>J S Mills, A. Bowers, Carl Djerassi and H.J. Ringold, Steroids CXXXVII. Synthesis of a New Class of Potent Cortical Hormones.  6α,9α-Difluoro-16α-Hydroxyprednisolone and its Acetonide, Journal of the American Chemical Society, 80, 3399-3404 (1960)</ref>。含有醋酸氟轻松的药膏最初以仙乃乐（Synalar）的注册商标进行销售。治疗皮肤病的药膏中使用的氟轻松的典型剂量为0.01-0.025％。但氟轻松作为一种外用類固醇藥物不能殺菌，反而會助長細菌滋生，所以不能用於感染性皮膚病，例如癬和疥瘡。<ref>{{cite web|title=長者常見之皮膚問題：藥物篇 |url=http://www.pcfhk.org/files/28433303.pdf |access-date=2020-09-15}}</ref>

== 副作用 ==
长期或大面积应用，可引起皮肤乾燥、變薄、軟化或變色。发生痤疮样皮炎和毛囊炎，增加对感染的易感染性等。<ref name="druguse"></ref><ref> {{cite web |url=https://skypost.ulifestyle.com.hk/article/2250737/MYRTUS%208%20MASK%E9%9D%A2%E8%86%9C%E5%90%AB%E9%A1%9E%E5%9B%BA%E9%86%87%20%E8%A1%9E%E7%94%9F%E7%BD%B2%E5%91%BC%E7%B1%B2%E5%81%9C%E7%94%A8%20%E9%81%8E%E9%87%8F%E4%BD%BF%E7%94%A8%E5%8F%AF%E8%87%B4%E5%9C%93%E8%87%89 |access-date=2020-09-16 |title=MYRTUS 8 MASK面膜含類固醇 衞生署呼籲停用 過量使用可致圓臉|publisher=晴報}}</ref>

== 參考資料 ==
{{Reflist|2}}

== 外部連結 ==
{{cite web |title=長者常見之皮膚問題：藥物篇| url=http://www.pcfhk.org/files/28433303.pdf |access-date=2020-09-15}}
{{皮質類固醇}}
[[Category:皮質類固醇|Category:皮質類固醇]]
[[Category:藥學|Category:藥學]]